跳至主要内容
临床试验/NCT04739228
NCT04739228已完成不适用

Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons With Skin Diseases: a Randomized-controlled Trial

European University of Rome2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
2
主要终点
Change from Pre-test to Post-test and Follow-up in Spiritual Well-Being, which will be reported in the outcome measure results data table as means and standard deviations.

研究概览

简要总结

We conducted a randomized-controlled trial of Guided Written Disclosure Protocol for dermatological patients with the aim of reducing psychological distress, expressive suppression, and skin-related symptoms, and improving spiritual well-being, cognitive reappraisal, and sense of coherence.

详细描述

Sample size assessment: A recent meta-analysis reported a study which showed that Guided Written Disclosure Protocol reach on effect size of 0.89 on psychosocial outcomes (Gidron et al., 2002; Mogk et al., 2006). Power analysis showed that with an alpha of 0.05 and a power of 0.80, we needed a sample of 34 participants to detect effect sizes of 0.89 and higher.

Plan for missing data: Occasional missing values were imputed by calculating, for each participant, the average score for each subscale and then replaced.

Statistical analysis plan: We conducted a 2 (group) X 2 (time [pre-treatment vs. post-treatment]) repeated measures multivariate analysis of variance (MANOVA) for a set of variables.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years;
  • Diagnosis of psoriasis or systemic sclerosis by a board-certified dermatologist.

排除标准

  • Patients with certified mental disorders (e.g., psychotic illness, major depressive disorder)
  • Patients undergoing psychotherapy for at least 6 months in the last 3 years;
  • Patients who currently receive psychopharmacological treatment.

结局指标

主要结局

Change from Pre-test to Post-test and Follow-up in Spiritual Well-Being, which will be reported in the outcome measure results data table as means and standard deviations.

时间窗: Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)

Spiritual well-being will be measured with the FACIT-Sp (minimum value=0; maximum value=48, with higher scores indicating a better outcome), a questionnaire assessing faith, peace and meaning

Change from Pre-test to Post-test and Follow-up in Psychological Distress, which will be reported in the outcome measure results data table as means and standard deviations.

时间窗: Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)

Psychological distress will be measured with the GHQ-12 (minimum value=1; maximum value=4, with higher score indicating greater outcome).

次要结局

  • Change from Pre-test to Post-test and Follow-up in Emotion Regulation, which will be reported in the outcome measure results data table as means and standard deviations.(Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment))
  • Change from Pre-test to Post-test and Follow-up in Skin-related Quality of Life, which will be reported in the outcome measure results data table as means and standard deviations.(Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment))
  • Change from Pre-test to Post-test and Follow-up in Sense of Coherence, which will be reported in the outcome measure results data table as means and standard deviations.(Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment))

研究者

发起方
European University of Rome
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Iani

Associate Professor

European University of Rome

研究点 (2)

Loading locations...

相似试验